The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting systemZheng Yang, Rong Li, Yuhuan Lv et al.|Nutrition Metabolism and Cardiovascular Diseases|2021Cited by 36
Association of the gallbladder or biliary diseases with dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: a meta-analysis of randomized controlled trialsMeng Yu, Rong Li, Zheng Yang et al.|Diabetology & Metabolic Syndrome|2022Cited by 4